Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin

British Journal of Dermatology

Volumn 140, Issue 4, 1999, Pages 656-660

  McKenna, D B ^a,b   Murphy, G M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Acitretin; Non melanoma skin cancer; Renal transplant recipients; Skin cancer chemoprophylaxis

Indexed keywords

ETRETIN; RETINOID;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CHEILITIS; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; DESQUAMATION; EPISTAXIS; FEMALE; HEADACHE; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; SKIN CANCER; XEROSIS;

ACITRETIN; ADULT; AGED; HUMANS; IMMUNOCOMPROMISED HOST; KERATOLYTIC AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0032927705     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02765.x     Document Type: Article

References (13)

1. 1 Kraemer KH, DiGiovanna JJ. Moshell AN et al. Prevention of skin cancer with oral 13-cis retinoic acid in xeroderma pigmentosum. N Engl J Med 1988; 318: 1633 -8.
2. 2 Peck GL, Gross EG, Butkus D, DiGiovanna J. Chemoprevention of basal cell carcinoma with isotretinoin. J Am Acad Dermatol 1982; 6: 815-23.
3. 3 Hartevelt MM, Bavinck JN, Kootte AMM et al. The incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-9.
4. 4 Storey A, Thomas M, Kalita A et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393: 229-34.
5. 5 McKerrow KJ, MacKie RM, Lesko MJ. Pearson C. The effect of oral retinoid therapy on the normal immune system. Br J Dermatol 1988; 119: 313-20.
6. 6 Shuttleworth D, Marks R, Griffin PJA, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988; 68: 717-24.
7. 7 Kelly JW, Sabto J, Gurr FW, Bruce F. Retinoids to prevent skin cancer in organ transplant recipients. (Letter.) Lancet 1991; 338: 1407.
8. 8 Vandeghinste N, De Bersaques J, Kint A. Acitretin as cancer chemoprophylaxis in a renal transplant recipient. Dermatology 1992; 185: 307-8.
9. 9 Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic lesions during acitretin therapy in renal transplant recipients: a double blind placebo controlled study. J Clin Oncol 1995; 13: 1933-8.
10. 10 Shudell EJ, McKenna DB, Murphy GM. Aggressive squamous cell carcinoma in the immunosuppressed. J Eur Acad Dermatol Venereol 1997; 9 (Suppl.): S146.
11. 11 Halliday M, Ho KK, Barnetson RSC. Regulation of the skin immune system by retinoids during carcinogenesis. J Invest Dermatol 1992; 99 (Suppl.): 83-6S.
12. 12 Berkhout RJM, Tieben LM, Smits HL et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33: 690-5.
13. 13 Khan MA, Jenkins GR, Tolleson WH et al. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes. Cancer Res 1991; 53: 905-9.